1. Home
  2. RGEN vs LSCC Comparison

RGEN vs LSCC Comparison

Compare RGEN & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LSCC
  • Stock Information
  • Founded
  • RGEN 1981
  • LSCC 1983
  • Country
  • RGEN United States
  • LSCC United States
  • Employees
  • RGEN N/A
  • LSCC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LSCC Semiconductors
  • Sector
  • RGEN Health Care
  • LSCC Technology
  • Exchange
  • RGEN Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • RGEN 8.2B
  • LSCC 7.3B
  • IPO Year
  • RGEN N/A
  • LSCC 1989
  • Fundamental
  • Price
  • RGEN $142.14
  • LSCC $50.72
  • Analyst Decision
  • RGEN Buy
  • LSCC Strong Buy
  • Analyst Count
  • RGEN 10
  • LSCC 12
  • Target Price
  • RGEN $190.25
  • LSCC $63.08
  • AVG Volume (30 Days)
  • RGEN 558.2K
  • LSCC 2.0M
  • Earning Date
  • RGEN 10-29-2024
  • LSCC 11-04-2024
  • Dividend Yield
  • RGEN N/A
  • LSCC N/A
  • EPS Growth
  • RGEN N/A
  • LSCC N/A
  • EPS
  • RGEN N/A
  • LSCC 1.36
  • Revenue
  • RGEN $602,354,000.00
  • LSCC $627,656,000.00
  • Revenue This Year
  • RGEN $0.35
  • LSCC N/A
  • Revenue Next Year
  • RGEN $12.36
  • LSCC $16.47
  • P/E Ratio
  • RGEN N/A
  • LSCC $37.20
  • Revenue Growth
  • RGEN N/A
  • LSCC N/A
  • 52 Week Low
  • RGEN $110.45
  • LSCC $40.65
  • 52 Week High
  • RGEN $211.13
  • LSCC $85.69
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 50.54
  • LSCC 49.98
  • Support Level
  • RGEN $136.94
  • LSCC $48.23
  • Resistance Level
  • RGEN $147.35
  • LSCC $52.86
  • Average True Range (ATR)
  • RGEN 5.38
  • LSCC 1.91
  • MACD
  • RGEN 0.45
  • LSCC -0.39
  • Stochastic Oscillator
  • RGEN 42.37
  • LSCC 44.86

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia.

Share on Social Networks: